Mirae Asset Healthcare Fund Regular-IDCW Reinvestment
Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return -0.21% at 05 Feb 2026 11:09 AM
Fund Details
NAV 21.693
Sub-Type Sectoral-Pharma
Rating 2
Min. SIP Amount ₹99.0
Fund Age(Year) 7.6
Fund Size(in Crores) 2770.83
Fund Performance
1 Month -4.16%
3 Month -5.29%
6 Month -4.94%
1 Year -0.21%
3 Year 21.34%
5 Year 14.43%
Know This Fund
As on 05 Feb 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (99.46%) Market Cap Small Cap 27.21 Mid Cap 42.68 Large Cap 29.57 Top Sectors Healthcare 97.65 Chemicals 1.22 Services 0.59 Top Holding Gland Pharma 1.81 JB Chemicals 3.1 Onesource Specialty Pharma 2.93 Sagility 0.59 Aurobindo Pharma 4.24 Laurus Labs 3.32 Sudeep Pharma 0.45 Glenmark Pharmaceuticals 6.91 Biocon 0.01 Lupin 5.23 Cohance Lifesciences 0.99 Syngene International 0.53 Divi's Laboratories 8.57 Torrent Pharmaceuticals 3 Dr. Reddy's Laboratories 4.34 Krishna Institute 3.17 Dr. Lal Pathlabs 0.62 Apollo Hospitals Enterprise 5.8 Rubicon Research 0.92 Wockhardt 0.05 Sai Life Sciences 2.69 Anthem Biosciences 1.24 Fortis Healthcare 4.22 Alkem Laboratories 3.25 Aster DM Healthcare 3.22 Neogen Chemicals 0.44 Sun Pharmaceutical Industries 12.44 CORONA Remedies 0.58 Cipla 5.55 Mankind Pharma 1.91 Deepak Nitrite 0.78 Eris Lifesciences 3.08 Ipca Laboratories 3.46
Debt & Others (0.55%) Sector Allocation Mutual Fund 0.01 Repo 0.68 Net Payables -0.15 Debt Credit Ratings Debt Category Mirae Asset Liquid Direct-G 0.01 Others 0.54
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -4.34% Ret 1Y -1.42% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -3.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 1.93%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Vrijesh Kasera
Education Mr. Kasera is a MBA (Finance), CFA (ICFAI).
Experience Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.
Tanmay Mehta
Education B.Com, C.A.
Experience Prior to joining the Mirae asset MF, he was associated with SBI capital markets.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 17
Date of Incorporation 2018-07-02
Total AUM 2025-12-31
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.